Trospium intravesicular

Drug Profile

Trospium intravesicular

Alternative Names: TAR 302; TAR-302-5018

Latest Information Update: 16 Jun 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator TARIS Biomedical
  • Class Antispasmodics; Benzhydryl compounds; Benzilates; Esters; Nortropanes; Small molecules; Spiro compounds
  • Mechanism of Action Cholinergic receptor antagonists; Muscarinic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase I Neurogenic bladder; Overactive bladder

Most Recent Events

  • 16 Jun 2017 Chemical structure information added
  • 24 Apr 2017 Phase-I clinical trials in Neurogenic bladder in USA (Intravesicular) (NCT03168828)
  • 01 Apr 2017 Phase-I clinical trials in Overactive bladder in USA (Intravesicular) (NCT03109379)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top